BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 233 filers reported holding BEAM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $286,363 | -13.4% | 11,907 | +15.0% | 0.00% | 0.0% |
| Q2 2023 | $330,731 | +5.2% | 10,358 | +0.8% | 0.00% | -50.0% |
| Q1 2023 | $314,529 | -15.5% | 10,272 | +7.9% | 0.00% | 0.0% |
| Q4 2022 | $372,405 | -18.5% | 9,522 | -0.8% | 0.00% | -33.3% |
| Q3 2022 | $457,000 | +10.9% | 9,601 | -9.8% | 0.00% | +50.0% |
| Q2 2022 | $412,000 | -25.1% | 10,639 | +10.9% | 0.00% | -33.3% |
| Q1 2022 | $550,000 | -25.1% | 9,596 | +4.1% | 0.00% | -25.0% |
| Q4 2021 | $734,000 | +7.3% | 9,216 | +17.2% | 0.00% | 0.0% |
| Q3 2021 | $684,000 | -26.5% | 7,863 | +8.7% | 0.00% | -20.0% |
| Q2 2021 | $931,000 | +104.6% | 7,233 | +27.3% | 0.01% | +66.7% |
| Q1 2021 | $455,000 | +158.5% | 5,681 | +163.3% | 0.00% | +200.0% |
| Q4 2020 | $176,000 | – | 2,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |